These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4318676)

  • 1. Adrenocortical secretion capacity during long-term corticotrophin treatment of neurological patients.
    Kytömäki O; Rinne UK
    Acta Neurol Scand; 1970; 46(S43):263-4. PubMed ID: 4318676
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract]   [Full Text] [Related]  

  • 3. The assessment of adrenal-cortical function in patients receiving corticotrophin therapy.
    Levell MJ; Stitch SR; Noronha M; Vas C
    Acta Endocrinol (Copenh); 1970 Jun; 64(2):287-94. PubMed ID: 4317517
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTH-induced adrenocortical response patterns in multiple sclerosis and their relation to the clinical effectiveness of ACTH therapy.
    Alexander L; Cass LJ
    Confin Neurol; 1971; 33(1):1-24. PubMed ID: 4323739
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticotrophin treatment in multiple sclerosis.
    Rinne UK; Sonninen V; Tuovinen T
    Acta Neurol Scand; 1968; 44(2):207-18. PubMed ID: 4301249
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of adrenal and pituitary stimulation tests in patients with multiple sclerosis.
    Ketelaer CJ; Delmotte P
    Acta Neurol Scand; 1972; 48(4):467-78. PubMed ID: 4342093
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticotrophin secreetion capacity after long-term corticotrophin treatment in multiple sclerosis.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(2):85-9. PubMed ID: 4303233
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldosterone secretion in steroid-treated patients with adrenal suppression.
    Thomas JP; el-Shaboury AH
    Lancet; 1971 Mar; 1(7700):623-5. PubMed ID: 4101232
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a synthetic 25 amino acid corticotrophin in normal man.
    Rose LI; Williams GH; Jagger PI; Lauler DP
    Clin Pharmacol Ther; 1968; 9(6):740-4. PubMed ID: 4301829
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of adrenocortical reserves with long-acting corticotropin preparations in the two-day intramuscular corticotropin test in man.
    Pekkarinen A; Rinne UK
    Scand J Clin Lab Invest Suppl; 1967; 100():127. PubMed ID: 4292205
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenocortical response upon repeated stimulation with corticotrophin in patients lacking endogenous corticotrophin secretion.
    Kolanowski J; Esselinckx W; Nagant de Deuxchaisnes C; Crabbe J
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):595-60. PubMed ID: 194448
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversed action of acetylated corticotrophin: inhibition of adreno-cortical secretion.
    Bulovskaya LN; Prokudina EA; Konstantinov VL; Tugunov SS; Dilman VM
    Acta Endocrinol (Copenh); 1969 Jun; 61(2):193-7. PubMed ID: 4308190
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenocortical stimulation by substituted 1-18 corticotrophin.
    Irvine WJ; Wilson KS; Toft AD
    Lancet; 1973 Jun; 1(7817):1417-9. PubMed ID: 4122986
    [No Abstract]   [Full Text] [Related]  

  • 14. ACTH vs. corticosteroids in therapy-utilize one and-or the other?
    Brandon ML
    Ann Allergy; 1972 May; 30(5):262-75. PubMed ID: 4336845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of high doses of synthetic ACTH on the function of the hypothalamo-hypophyseal-adrenal cortex system].
    Walser A; Barthe P; Schär J
    Schweiz Med Wochenschr; 1968 Nov; 98(48):1892-5. PubMed ID: 4303138
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticotrophin secretion capacity in multiple sclerosis.
    Rinne UK
    Eur Neurol; 1968; 1(4):221-33. PubMed ID: 4301627
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of a new long-acting (Zn) synthetic ACTH (CIBA 36716 Ba-24 corticotrophin) on adrenal secretion in human subjects.
    Gilboa Y; Ber A; Winkelsberg G
    J Clin Endocrinol Metab; 1966 Jun; 26(6):666-8. PubMed ID: 4287990
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary adrenocortical function in multiple sclerosis.
    Cazzullo CL; Piotti LE; Montanini R; Montalbetti N; Bonini PA; Marforio S
    Life Sci; 1968 Feb; 7(3):137-44. PubMed ID: 4295758
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenocortical response to high dosage ACTH therapy in patients with multiple sclerosis.
    Alexander L; Cass LJ; Enders M; Sarai K
    Confin Neurol; 1966; 28(1):1-17. PubMed ID: 4290212
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical adrenal hyperfunction: in vivo studies and incubations of adrenal tissue with 4-14C progestrone.
    Goldzieher JW; Axelrod LR; Weissbein AS
    Acta Endocrinol (Copenh); 1968; 58():Suppl 129:5-34. PubMed ID: 4297487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.